Drug-Eluting Balloons

This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.

News | September 16, 2011

September 15, 2011 – The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first...

News | September 15, 2011

September 15, 2011 — Very positive results were reported in the first account of a clinical study evaluating the...

News | July 26, 2011

July 26, 2011 – The first patient has been enrolled in the LEVANT 2 clinical trial, a global, multi-center,...

News | May 18, 2011

May 17, 2011 - Medrad Inc., a business of Bayer HealthCare, today announced it has received CE Mark for its...

News | November 17, 2010

November 17, 2010 – A drug-eluting balloon (DEB) and a coronary stent have received CE mark approval in Europe. The...

News | September 29, 2010

September 29, 2010 – Results from a trial studying the effects of a drug-eluting balloon (DEB) on...

News | May 25, 2010

May 25, 2010 – The first patient has been implanted with a bare metal coronary stent mounted on a drug-...

The Paccocath coating of the B.Braun SeQuent Please DEB uses contrast media to separate and evenly distribute the paclitaxel molecules over the surface of the balloon. The anti-proliferative drug helps prevent restenosis.

Feature | May 03, 2010 | Dave Fornell

Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others...

An illustration showing how the Amphirion_drug-eluting, drug-coated balloon technology works.

Invatec developed the FreePac balloon coating, which uses a urea matrix to free and separate paclitaxel molecules and facilitates their absorption into the blood vessel wall.

Feature | Drug-Eluting Balloons | May 03, 2010 | Dave Fornell

Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs...

A radio frequency plaque ablation system is combined inside the Minnow Guiding Reshaping Technology balloon catheter.

Feature | May 02, 2010 | By Stephanie Labelle, senior analyst, Millennium Research Group

In recent years, many medical device companies saw the underserved lower extremity as an opportunity to...

The SeQuent Please drug-eluting balloon catheter was cleared for use in Europe in 2009.

News | February 22, 2010

February 22, 2010 – As part of a comarketing and trademark license agreement between MEDRAD Inc. and B....

Medtronic's purchased of Invatec will expand its portfolio of devices to treat peripheral artery disease (PAD).

News | January 25, 2010

January 25, 2010 – Expanding its peripheral vascular disease product offerings, Medtronic Inc. today signed...

Invatec's IN.PACT Amphirion paclitaxel-eluting PTA balloon catheter features FreePac, a proprietary coating that frees and separates paclitaxel molecules and facilitates their absorption into the artery wall.

Feature | June 23, 2009 | Dave Fornell

The focus on balloon angioplasty largely slipped from the interventional limelight a decade ago after the...

The first photo shows a control in a porcine artery treated with a conventional uncoated balloon, showing massive neointimal proliferation. The second photo shows a different section of the same artery treated with a IN.PACT paclitaxel-coated balloon.

News | May 19, 2009

May 19, 2009 - Invatec announced today the availability of its newly CE-marked coronary balloon, the IN....

News | March 16, 2009

March 16, 2009 – Invatec today announced CE-certification of a new coronary balloon, the IN.PACT Falcon...

Overlay Init